PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 27 results · Social Media & Digital · Obesity & Weight Management  · Clear
🔒 Subscribers only
AUTH/3754/3/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A concerned health professional found that a booking form for a “Free Weight Management Course (WEBINAR + PGD)” was still accessible online via a specific Google search term.The form related to…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3763/4/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Two academic complainants raised concerns about Novo Nordisk’s Disclosure UK reporting and third-party activities linked to a training provider and a pharmacy services provider. Transfers of valu…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3821/9/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous health professional complained about Saxenda (liraglutide 3mg) in the context of GLP-1 supply shortages and alleged Novo Nordisk continued to promote Saxenda despite supply issues.The …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3867/12/23
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code after employee reposted Financial Times LinkedIn post mentioning Weg
An anonymous, non-contactable complainant (self-described health professional) raised concerns about a Novo Nordisk employee’s LinkedIn activity involving a Financial Times (FT) post.The employee…
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3737/2/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code over Saxenda leavepiece
A health professional complained about a Saxenda (liraglutide) promotional leavepiece (UK20SX00030), described as an “HCP discussion guide”. The complainant alleged the leavepiece was freely av…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3738/2/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Novo Nordisk made a voluntary admission after an internal investigation linked to Case AUTH/3711/11/22.The issue concerned a weight management and obesity “hub” hosted on a named UK pharmacists…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3604/1/22
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A UK-based individual contracted to work for Novo Nordisk A/S (via a third-party talent acquisition company) posted on LinkedIn (approx. June 2021).The post referenced a planned phase 3a trial of �…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3640/5/22
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Novo Nordisk made a voluntary admission about a promotional email to health professionals stating Novo Nordisk UK had no issues with supply of Ozempic (semaglutide) and Rybelsus (semaglutide) (GLP-…
Clauses: 9.1
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3711/11/22
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached Clause 5.5 over unclear involvement in pharmacist obesity hub and documents (A
A UK health professional complained about a password-protected weight management and obesity “hub” hosted on a UK pharmacist association’s website, developed under a Collaborative Working (CW…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3456/1/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Boehringer Ingelheim & Eli Lilly
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3545/7/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached Clause 5.1 after listing an 0845 number for side-effect reporting on Saxenda p
A UK health professional complained that the Saxenda (liraglutide) patient website (www.saxenda.co.uk) listed an 0845 telephone number under “Reporting of side effects” for reporting adverse ev…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3483/3/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Eli Lilly
A UK health professional complained about a LinkedIn post about an investigational medicine being ‘liked’ by UK-based staff, allegedly promoting it to the UK public.The post was on the Eli Lill…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3523/6/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A UK health professional complained about a LinkedIn post made (June 2021) by an individual contracted to work for Novo Nordisk A/S (Denmark) via a third-party talent acquisition agency.The post st…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3525/6/21
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A UK health professional complained about a LinkedIn post by a clinical training provider advertising a FREE weight management webinar with “funding to get you started”. The LinkedIn post linke…
Clauses: 3.2,9.1
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3315/3/20
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An individual complained about two LinkedIn posts about obesity made by Novo Nordisk employees around World Obesity Day 2020.The posts included pledges such as “Help stamp out weight stigma”, �…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3333/4/20
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous complainant (self-described health professional) attended CCR (Clinical, Cosmetic, Regenerative) medical aesthetics exhibition in London (Oct 2019) and alleged Novo Nordisk promoted th…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3299/1/20
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code over Saxenda materials at fertility conference lacking prominent pre
A named individual complained about Novo Nordisk’s promotion of Saxenda (liraglutide) at the British Fertility Conference (January 2020).Saxenda’s SPC (Section 4.6) stated it should not be used…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3173/3/19
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous, contactable health professional complained that Novo Nordisk and its employees were linked to companies allegedly advertising, distributing and selling Saxenda (liraglutide) directly …
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3109/10/18
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
AstraZeneca website
A UK health professional complained about AstraZeneca UK’s HCP medicines website pages for Forxiga (dapagliflozin), Onglyza (saxagliptin) and Symbicort (budesonide/formoterol).Forxiga: complaint …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2793/9/15
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
AstraZeneca Forxiga EMIS Web ‘9 step guide’ ruled misleading; corrective statement and public reprim
A clinical pharmacist complained about an AstraZeneca leavepiece giving EMIS Web instructions to identify “uncontrolled and overweight” type 2 diabetes patients who “may be suitable” for Fo…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2653/11/13
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi
Novo Nordisk complained about a Sanofi promotional presentation for Lyxumia (lixisenatide) used in remote (internet-based) sales calls with health professionals (ref GBIE.LYX.13.02.15).The presenta…
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2482/2/12
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk email invite to Diabetes UK symposium
An anonymous, contactable complainant received an email invitation (ref UK/DB/0112/0028b) to a Novo Nordisk satellite symposium at Diabetes UK 2012: “Weighing up the benefits: the practical use o…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2382/1/11
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A general practitioner complained about Daily Mail (Mail Online) articles referring to liraglutide (Victoza), a prescription-only medicine indicated for adults with type 2 diabetes to achieve glyca…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2318/5/10
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Clauses: NONE
2010 🔒 Subscribe
1 2 Next → Page 1 of 2 — 27 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews